Dallas, TX -- (SBWIRE) -- 09/12/2014 -- The expanding economy of China is one of the major trends witnessed in this market. The Government of China is making efforts to improve healthcare infrastructures, which has benefited the POCT market.
Analysts forecast the POCT market in China to grow at a CAGR of 20.69 percent over the period 2013-2018. According to the report, one of the major drivers in the market is the increase in innovations in technology to provide efficient and inexpensive devices to diagnose and treat diseases. Advances in technology and innovations in the Healthcare industry have resulted in the development of equipment with technology that is customized as per the needs of the patient.
POCT, also called near-patient testing, is performed outside a clinical laboratory. It helps in making fast clinical decisions, and hence in administrating appropriate treatments and medication. POCT is gaining popularity due to the increasing incidence and prevalence of lifestyle diseases such as diabetes, heart disease, and obesity. It is generally cost-effective and user-friendly. POCT devices are standardized to minimize errors during the diagnosis of patients. POCT plays a major role in improving patients' quality of life.
Covered in this Report
This report covers the present scenario and the growth prospects of the POCT market in China for the period 2014-2018. To calculate the market size, the report considers the revenue generated through the following applications of POCT:
- Blood glucose testing
- Cholesterol testing
- Infectious disease testing
- Blood gas testing
- Cardiac biomarkers testing
- Pregnancy testing
- Others (such as cancer biomarker, electrolyte analyzers, blood coagulation testing, tumor marker, and urinalysis testing)
Order a copy of this report at (Prices start at US$2500 for a single user PDF) http://www.reportsnreports.com/purchase.aspx?name=297738.
The POCT Market in China 2014-2018 has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers China; it also covers the landscape of the POCT market in China and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
The report recognizes the following companies as the key players in the Point of Care Testing (POCT) Market in China: Abbott Laboratories, Bayer HealthCare AG, F. Hoffmann-La Roche Ltd. and LifeScan Inc.
Other Prominent Vendors in the market are: Bioptik Technology, Chongqing Haray International Business, Fudakang Ind'l, Guangzhou Maya Medical Equipment, Jiangxi Zhongchenda Industrial Investment, Nantong Voyage International Trade, Shenzhen Fitconn Technology, Shiny Health Import & Export, Sunrising Enterprise, Wuhan HNC Technology and Yuan Yu Bio-Tech.
Market Driver
- Technological Innovations
- For a full, detailed list, view our report
Market Trend
- Expanding Economy of China
- For a full, detailed list, view our report
Further, the report states that one of the major challenges in the market is the advances in technology. The entry of new technology in the market forces the frequent elimination of the POCT products of the large vendors.
Key Questions Answered in this Report
- What will the market size be in 2018 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?